Colorectal Cancer Screening
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Illinois Policy RPLAB071 alerts
Get alerted when Policy RPLAB071 changes without checking for updates manually.
Monitor payer policy activity
This reimbursement policy governs when colorectal cancer screening services may be reimbursable for asymptomatic individuals and identifies screening methods that are not reimbursable. Providers must submit accurate coding and documentation, subject to applicable plan documents, contracts, and claim review.
The policy added potential reimbursement for multi-target stool DNA and multi-target stool RNA screening once every three years for asymptomatic individuals ages 45 through 75.
The policy added a nonreimbursement rule when a different approved multi-target stool-based test is used within three years after a prior multi-target stool-based test.
Procedure code 0421U was added to the policy's code list.
Procedure code 0500T was removed from the policy's code list.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.